NicCheck I the only rapid CLIA waived urine test for nicotine and cotinine is now available to doctor’s offices through PSS (Physicians Sales and Service, Inc.)
Wednesday January 21, 2009, Milford, MA- Mossman Associates, Inc. is pleased to announce that NicCheck is now conveniently available through PSS (Physician Sales & Service, Inc.).
Physician Sales & Service, Inc. was founded in 1983 with a mission to fulfill the inventory needs of office-based physicians by providing unique and innovative services. Based in Jacksonville, FL, PSS has grown into the country’s largest provider of medical supplies to the physician market through its commitment to fast service.
“We are happy to be able to have PSS make available our test to the numerous physician’s offices that they visit on a regular basis. The addition of all of these sales representatives is a major step forward in our efforts to get further exposure in the primary care market”, commented Donald Mossman, President of Mossman Associates, Inc.
“PSS joins others such as the on-line outlets Cliawaived.com and Testcountry.com as distributors of NicCheck, although our company can still be contacted for direct sales as we continue to ship the product worldwide”. Our test, which was originally developed at DynaGen Inc, Cambridge Massachusetts, has been used in physician’s offices since the mid 1990’s worldwide and has become an integral part of the Japanese Health Manual" further comments Don Mossman.
About Mossman Associates, Inc.
Mossman Associates, Inc is a private medical device company that specializes in rapid tests for physicians and researchers as well as equipment and reagents for the biotech industry. Incorporated in 2001 the professionals at Mossman Associates Inc have been involved with cutting edge technology for over 30 years.
Donald Mossman, President
Mossman Associates, Inc.
9 Village Circle, Milford, MA 01757
508-488-6169 508-488-6169 (P)
508-418-1397 (F)
contact@mossmanassociates.com
Wednesday, January 21, 2009
NicCheck I (formerly from DynaGen Inc) Distributed By Physicians Sales and Services, Inc. (PSS) to Physician’s Offices
Labels:
NicCheck
Tuesday, September 23, 2008
NicCheckTM Used To Confirm Smoking Cessation Within The International Quit & Win 2008 Smoking Cessation Competition
Labels:
NicCheck
NicCheck once again to be the rapid test of choice of participants within the Quit and Win contest to confirm smoking cessation
Milford, Massachusetts; 9/23/08 - Mossman Associates, Inc. announced today that NicCheck was used once again within the International Quit & Win 2008 contest. Participants within this worldwide smoking cessation competition, has chosen NicCheck I once again to be the rapid test they used to confirm smoking cessation. The program is sponsored by National Public Health Institute, KTL of Helsinki, Finland in collaboration with WHO (WHO/HQ/NPH).
Quit&Win has rapidly grown in popularity as a practical international smoking cessation activity. Quit&Win began in 1994 with just 13 countries participating. Since then, the competition has taken place internationally every two years.
Donald Mossman, President of Mossman Associates is quoted as saying “We are pleased to be involved with this important project once again. We have received positive feedback from such people as those at The John Tung Foundation, Taiwan, where they said “Thanks to the NicCheck Kits, we had successfully held the campaign and helped nearly 20,000 people to experience the good of quitting smoking”. Similar sentiments are expressed by Anti-Smoking activists in Malta, Canada any many other areas around the world.”
NicCheck (formerly a product of DynaGen Inc) is used worldwide to aid in smoking cessation programs, general health and surgical hospitals.
For more information contact:
Donald Mossman
President
Mossman Associates Inc
9 Village Circle
Milford, MA 01757
www.nicotinetesting.com
www.mossmanassociates.com
Milford, Massachusetts; 9/23/08 - Mossman Associates, Inc. announced today that NicCheck was used once again within the International Quit & Win 2008 contest. Participants within this worldwide smoking cessation competition, has chosen NicCheck I once again to be the rapid test they used to confirm smoking cessation. The program is sponsored by National Public Health Institute, KTL of Helsinki, Finland in collaboration with WHO (WHO/HQ/NPH).
Quit&Win has rapidly grown in popularity as a practical international smoking cessation activity. Quit&Win began in 1994 with just 13 countries participating. Since then, the competition has taken place internationally every two years.
Donald Mossman, President of Mossman Associates is quoted as saying “We are pleased to be involved with this important project once again. We have received positive feedback from such people as those at The John Tung Foundation, Taiwan, where they said “Thanks to the NicCheck Kits, we had successfully held the campaign and helped nearly 20,000 people to experience the good of quitting smoking”. Similar sentiments are expressed by Anti-Smoking activists in Malta, Canada any many other areas around the world.”
NicCheck (formerly a product of DynaGen Inc) is used worldwide to aid in smoking cessation programs, general health and surgical hospitals.
For more information contact:
Donald Mossman
President
Mossman Associates Inc
9 Village Circle
Milford, MA 01757
www.nicotinetesting.com
www.mossmanassociates.com
Saturday, May 3, 2008
NicCheck I Test (formerly from DynaGen Inc) Used By STICKK.COM For Smoking Cessation Commitments, By Confirming Individuals Smoking Status
Labels:
NicCheck
STICKK.COM, A New Website Helping With Smoking Cessation Uses NicCheck I to confirm smoking status.
Friday, March 3, 2008 Mossman Associates, Inc. announced today that they have joined with STICKK.COM to assist in a smoking cessation project. The website launched in just recently promotes healthier, happier living, by helping individuals and groups make and fulfill commitments to improve their lives. StickK.com does this by providing an easy mechanism for individuals to post financial commitments to achieve goals such as lose weight, stop smoking, look for love, train for a marathon, go green, etc.
Research by members of the stickK.com scientific advisory board, and others, shows that financial contracts like this can make individuals up to three times more likely to achieve goals such as smoking cessation and weight loss.
Donald Mossman, President of Mossman Associates is quoted as saying "We are pleased to be involved with this project and continue to be involved with smoking cessation projects around the world. Our test, NicCheck I, can be used to enable doctors or the smoker themselves to better determine the amount of Nicotine Replacement Therapy (NRT) they require. NicCheck can be used as a positive reinforcement tool during this difficult process by being a visual aid to the person showing the reduction in nicotine circulating in their bodies as they quit. This test, which was originally developed at DynaGen Inc, Cambridge Massachusetts, has been used since the mid 1990’s for such purposes. We feel strongly that the addition of NicCheck to the tools currently available will be an aid in the successful completion of a person’s smoking cessation efforts".
Donald Mossman, President
Mossman Associates, Inc.
9 Village Circle, Milford, MA 01757
508-488-6169 (P) 508-418-1397 (F)
contact@mossmanassociates.com
Monday, October 15, 2007
Innovations for Poverty Action, Teams with The Green Bank of Caraga, Using NicCheckTM to Confirm Smoking Cessation
Labels:
NicCheck
Milford, Massachusetts; 10/15/07 - Mossman Associates Inc. is pleased to announce that our NicCheckTM is being used by Innovations for Poverty Action and The Green Bank of Caraga within their CARES Campaign.
CARES, (Committed Action to Reduce and End Smoking), offered by The Green Bank of Caraga, aims at supporting smokers to quit smoking. Despite the widely known negative effects of smoking on health, smoking continues to be prevalent in many Filipino families in the absence of organized smoking cessation programs.
The CARES product allows smokers to commit to quitting within the next six months, and provides smokers with financial incentives to follow through on that commitment. Once a client opens a CARES savings account and commits to quit smoking in six months, the client will not have the access to the savings account unless he/she passes the nicotine test at the end of the six months period. The Green Bank provides deposit collection services on weekly basis, constantly reminding and encouraging the client to reduce smoking and eventually quit.
Ann Mayuga from the Innovations for Poverty Action is quoted as saying, “ Clients are encouraged to stop smoking within 6 months with the incentives provided by the CARES product. We use NicCheck to confirm that participants have truly quit smoking during this period. The NicCheck test is affordable and easy to use. We are able to reduce the hassle for the clients by having the CARES staff visit each client and conduct the test in the field.”
Donald Mossman, President of Mossman Associates Inc. notes, "We are proud to be able to contribute to a program designed to help those people trying to quit smoking. Our NicCheck product can effectively be used to monitor a person’s nicotine consumption as they reduce their dependence, as well as, to verify total cessation. The test is simple and as you can see because it is a rapid visual test it is conducive to being run in the field, lending itself to visiting nurses, spot checks and remote health stations”.
For more information contact:
Donald Mossman, President
Mossman Associates Inc.
9 Village circle
Milford, MA 01757
www.nicotinetesting.com
Wednesday, March 1, 2006
International Quit &Win 2006 Smoking Cessation Competition Uses NicCheck To Confirm Smoking Cessation
Labels:
NicCheck
The International Quit&Win 2006, a world wide smoking cessation competition, has chosen NicCheck once again to be the test they used to confirm smoking cessation.
Wed Mar 01 2006] Mossman Associates, Inc. announced today that the International Quit&Win 2006, a world wide smoking cessation competition, has chosen NicCheck I once again to be the test they used to confirm smoking cessation. The program which takes place every 2 years is sponsored by National Public Health Institute, KTL of Helsinki, Finland in collaboration with WHO (WHO/HQ/NPH). Quit&Win is a “Practical Collaboration For Global Tobacco Cessation” and a cost-effective way to reduce smoking among the population. The international experience shows that Quit&Win can easily be implemented in different populations and cultures.
All contestants had smoked daily for at least one year and are 18 years of age or older. The contestants are required to abstain from smoking for at least four weeks, which is verified with a urine test among the winners. The test chosen once again is NicCheck.
Quit&Win has rapidly grown in popularity as a practical international smoking cessation activity. Quit & Win began in 1994 with just 13 countries participating. Since then, the competition has taken place internationally every two years. For more information please visit http://www.quitandwin.org/portal/en/news/?id=52
Donald Mossman, President of Mossman Associates is quoted as saying “We are pleased to be involved with this important project once again and we dedicate 2006 to becoming more involved with smoking cessation projects in general. We have seen how our test can be used to enable doctors and eventually the smoker themselves to better determine the amount of Nicotine Replacement Therapy they require and also how the test can be used as a positive reinforcement tool in this difficult process. We feel strongly that the addition of NicCheck to the tools currently available will be an aid in the successful completion of anyone’s smoking cessation efforts”.
For more information contact:
Donald Mossman
President
Mossman Associates Inc.
9 Village Circle
Milford, MA 01757
www.nicotinetesting.com
www.mossmanassociates.com
Wed Mar 01 2006] Mossman Associates, Inc. announced today that the International Quit&Win 2006, a world wide smoking cessation competition, has chosen NicCheck I once again to be the test they used to confirm smoking cessation. The program which takes place every 2 years is sponsored by National Public Health Institute, KTL of Helsinki, Finland in collaboration with WHO (WHO/HQ/NPH). Quit&Win is a “Practical Collaboration For Global Tobacco Cessation” and a cost-effective way to reduce smoking among the population. The international experience shows that Quit&Win can easily be implemented in different populations and cultures.
All contestants had smoked daily for at least one year and are 18 years of age or older. The contestants are required to abstain from smoking for at least four weeks, which is verified with a urine test among the winners. The test chosen once again is NicCheck.
Quit&Win has rapidly grown in popularity as a practical international smoking cessation activity. Quit & Win began in 1994 with just 13 countries participating. Since then, the competition has taken place internationally every two years. For more information please visit http://www.quitandwin.org/portal/en/news/?id=52
Donald Mossman, President of Mossman Associates is quoted as saying “We are pleased to be involved with this important project once again and we dedicate 2006 to becoming more involved with smoking cessation projects in general. We have seen how our test can be used to enable doctors and eventually the smoker themselves to better determine the amount of Nicotine Replacement Therapy they require and also how the test can be used as a positive reinforcement tool in this difficult process. We feel strongly that the addition of NicCheck to the tools currently available will be an aid in the successful completion of anyone’s smoking cessation efforts”.
For more information contact:
Donald Mossman
President
Mossman Associates Inc.
9 Village Circle
Milford, MA 01757
www.nicotinetesting.com
www.mossmanassociates.com
Wednesday, June 8, 2005
Dutch Cancer Society Using NicCheck to Confirm Smoking Cessation
Labels:
NicCheck
Milford, Massachusetts; 6/8/05 - Mossman Associates Inc. is pleased to announce that their NicCheck is being used by The Dutch Cancer Society for their annual Quit and Win Campaign.
Quit &Win is a practical, cost-effective evidence-based smoking cessation method for population-wide public health use. The International Quit &Win Campaign, originally organized in the framework of the WHO/CINDI program, is now an international network supported by the WHO and organized by The National Public Health Institute, KTL, Helsinki Finland. Quit &Win has proven to have the capability to reach more smokers and at a lower cost than most smoking cessation interventions. It has also proven to be applicable to different cultures. The success of the Quit &Win campaigns are assessed by standardized evaluation procedures, and follow-up studies have shown that after one year, on an average 20 % of the participants have remained tobacco free.
This stop-smoking-contest is conducted worldwide every two years by The National Public Health Institute, KTL, Helsinki Finland, however in the Netherlands there will be a contest every year organized under the same rules and conditions as the parent contest and overseen by The Dutch Cancer Society.
Ingrid van den Berg from the Dutch Cancer Society is quoted as saying,
"The Dutch Cancer Society is annually organizing a Quit &Win campaign. In May 2005, 3.695 smokers quit smoking in the Netherlands. Participants could win €1.000, if they quit smoking for at least a month. In order to check if the potential winners truly quit smoking during this period, we used NicCheck to confirm if they indeed were smoke free after a month"
"We are proud to be able to contribute to a program designed to help those people trying to quit smoking, to ultimately succeed. Our NicCheck product can effectively be used to monitor a person’s nicotine consumption as they reduce their dependence, as well as, to verify total cessation", notes Donald Mossman, President of Mossman Associates Inc.
More information on the contest can be reviewed at www.quitenwin.nl or http://www.quitandwin.org/fi/content/sisallot/contact/03links?C:D=54583&C:selres=54583 for the worldwide contest.
For more information contact:
Donald Mossman
President
Mossman Associates Inc.
9 Village Circle
Milford, MA 01757
www.nicotinetesting.com
Quit &Win is a practical, cost-effective evidence-based smoking cessation method for population-wide public health use. The International Quit &Win Campaign, originally organized in the framework of the WHO/CINDI program, is now an international network supported by the WHO and organized by The National Public Health Institute, KTL, Helsinki Finland. Quit &Win has proven to have the capability to reach more smokers and at a lower cost than most smoking cessation interventions. It has also proven to be applicable to different cultures. The success of the Quit &Win campaigns are assessed by standardized evaluation procedures, and follow-up studies have shown that after one year, on an average 20 % of the participants have remained tobacco free.
This stop-smoking-contest is conducted worldwide every two years by The National Public Health Institute, KTL, Helsinki Finland, however in the Netherlands there will be a contest every year organized under the same rules and conditions as the parent contest and overseen by The Dutch Cancer Society.
Ingrid van den Berg from the Dutch Cancer Society is quoted as saying,
"The Dutch Cancer Society is annually organizing a Quit &Win campaign. In May 2005, 3.695 smokers quit smoking in the Netherlands. Participants could win €1.000, if they quit smoking for at least a month. In order to check if the potential winners truly quit smoking during this period, we used NicCheck to confirm if they indeed were smoke free after a month"
"We are proud to be able to contribute to a program designed to help those people trying to quit smoking, to ultimately succeed. Our NicCheck product can effectively be used to monitor a person’s nicotine consumption as they reduce their dependence, as well as, to verify total cessation", notes Donald Mossman, President of Mossman Associates Inc.
More information on the contest can be reviewed at www.quitenwin.nl or http://www.quitandwin.org/fi/content/sisallot/contact/03links?C:D=54583&C:selres=54583 for the worldwide contest.
For more information contact:
Donald Mossman
President
Mossman Associates Inc.
9 Village Circle
Milford, MA 01757
www.nicotinetesting.com
Thursday, February 10, 2005
MycoDot TM Continues To Provide Rapid Serological Tuberculosis Testing In Japan
Labels:
MycoDot
Milford, Massachusetts; 2/10/05 - Mossman Associates, Inc. announced today that hundreds of thousands of their serological TB tests- MycoDot have been successfully used in the diagnosis of that disease in Japan.
MycoDot provides the Japanese the opportunity to diagnose TB within 20 minutes using a very small amount of serum or whole blood saving major amounts of time as well as establishing cost controls.
“The approval to market MycoDot in JAPAN by the Kosheio, the Japanese version of the FDA, was a major step in the acceptance of the serological testing of tuberculosis. Under the watchful eye and monitoring of the Kosheio, MycoDot continues to provide test results with high sensitivity and excellent specificity” notes Donald Mossman, President, Mossman Associates Inc. Mr. Mossman continues “we, like the majority of people working the TB space, feel that the proper identification of the disease is critical in controlling the problem. We are glad to be part of the efforts to improve upon the current TB diagnostic technology that is used in the public sector, which has not changed much in over 100 years”.
Mossman Associates, Inc. also provides reagents to other manufactures of diagnostics such as Bio-Chips, ELISA, Comb Technology, and Lateral Flow Devices.
For more information, please contact:
Donald Mossman
President
Mossman Associates Inc.
9 Village Circle.
Milford, MA 01757
MycoDot provides the Japanese the opportunity to diagnose TB within 20 minutes using a very small amount of serum or whole blood saving major amounts of time as well as establishing cost controls.
“The approval to market MycoDot in JAPAN by the Kosheio, the Japanese version of the FDA, was a major step in the acceptance of the serological testing of tuberculosis. Under the watchful eye and monitoring of the Kosheio, MycoDot continues to provide test results with high sensitivity and excellent specificity” notes Donald Mossman, President, Mossman Associates Inc. Mr. Mossman continues “we, like the majority of people working the TB space, feel that the proper identification of the disease is critical in controlling the problem. We are glad to be part of the efforts to improve upon the current TB diagnostic technology that is used in the public sector, which has not changed much in over 100 years”.
Mossman Associates, Inc. also provides reagents to other manufactures of diagnostics such as Bio-Chips, ELISA, Comb Technology, and Lateral Flow Devices.
For more information, please contact:
Donald Mossman
President
Mossman Associates Inc.
9 Village Circle.
Milford, MA 01757
Subscribe to:
Posts (Atom)
